Evidence map›Paper›PMID 39328314›Full record

ArticleFrontiers in medicine2024

Antifungal activity of indolicidin-derived peptide In-58 against

Sushan Li, Zhanhan Tang, Zhe Liu, Sha Lv, Chunli Yao, Shuang Wang, Fuqiu Li

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Essential oil fromFrontiers in fungal biology · 2026
    Article
  2. Review
  3. Silencing ofJournal of fungi (Basel, Switzerland) · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Sushan LiDepartment of Dermatology, The Second Hospital of Jilin University, Changchun, China.
Zhanhan TangDepartment of Dermatology, The Second Hospital of Jilin University, Changchun, China.
Zhe LiuDepartment of Dermatology, The Second Hospital of Jilin University, Changchun, China.
Sha LvDepartment of Dermatology, The Second Hospital of Jilin University, Changchun, China.
Chunli YaoDepartment of Dermatology, The Second Hospital of Jilin University, Changchun, China.
Shuang WangDepartment of Dermatology, The Second Hospital of Jilin University, Changchun, China.
Fuqiu LiDepartment of Dermatology, The Second Hospital of Jilin University, Changchun, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In-58, a peptide derived from indolicidin, shows extraordinary antibacterial activity and lower toxicity than indolicidin toward mammalian cells. Here, we investigated the antifungal activity of In-58 against the human pathogen

Indexed as

antifungal activityantimicrobial peptideGalleria mellonellaindolicidin derivativeSporothrix globosa

Identifiers

PMID39328314
PMCPMC11424419

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.